These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17944486)

  • 1. Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope.
    O'Nuallain B; Allen A; Ataman D; Weiss DT; Solomon A; Wall JS
    Biochemistry; 2007 Nov; 46(45):13049-58. PubMed ID: 17944486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains.
    O'Nuallain B; Allen A; Kennel SJ; Weiss DT; Solomon A; Wall JS
    Biochemistry; 2007 Feb; 46(5):1240-7. PubMed ID: 17260953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for amyloid fibril formation in immunoglobulin light chains based on comparison of amyloidogenic and benign proteins and specific antibody binding.
    Khurana R; Souillac PO; Coats AC; Minert L; Ionescu-Zanetti C; Carter SA; Solomon A; Fink AL
    Amyloid; 2003 Jun; 10(2):97-109. PubMed ID: 12964417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacy.
    Wall JS; Williams AD; Foster JS; Richey T; Stuckey A; Macy S; Wooliver C; Campagna SR; Tague ED; Farmer AT; Lands RH; Martin EB; Heidel RE; Kennel SJ
    Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10839-E10848. PubMed ID: 30377267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins.
    Stevens PW; Raffen R; Hanson DK; Deng YL; Berrios-Hammond M; Westholm FA; Murphy C; Eulitz M; Wetzel R; Solomon A
    Protein Sci; 1995 Mar; 4(3):421-32. PubMed ID: 7795526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein.
    Engvig JP; Olsen KE; Gislefoss RE; Sletten K; Wahlström O; Westermark P
    Scand J Immunol; 1998 Jul; 48(1):92-8. PubMed ID: 9714416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of the amyloidogenic kappa Bence Jones protein (FUR).
    Odani S; Komori Y; Gejyo F
    Amyloid; 1999 Jun; 6(2):77-88. PubMed ID: 10439113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
    Frangione B; Moloshok T; Solomon A
    J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils.
    Wall JS; Kennel SJ; Williams A; Richey T; Stuckey A; Huang Y; Macy S; Donnell R; Barbour R; Seubert P; Schenk D
    PLoS One; 2012; 7(12):e52686. PubMed ID: 23300743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues.
    Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K
    Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a peptide mimotope to guide the humanization of MRK-16, an anti-P-glycoprotein monoclonal antibody.
    Tang Y; Beuerlein G; Pecht G; Chilton T; Huse WD; Watkins JD
    J Biol Chem; 1999 Sep; 274(39):27371-8. PubMed ID: 10488067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The primary structure of a monoclonic immunoglobulin-L-chain of subgroup IV of the kappa type (Bence-Jones protein Len.)].
    Schneider M; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1975 May; 356(5):507-57. PubMed ID: 50995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies.
    Abe M; Goto T; Kennel SJ; Wolfenbarger D; Macy SD; Weiss DT; Solomon A
    Am J Clin Pathol; 1993 Jul; 100(1):67-74. PubMed ID: 7688492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
    Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
    Elife; 2020 Mar; 9():. PubMed ID: 32151314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seeded fibrils of the germline variant of human λ-III immunoglobulin light chain FOR005 have a similar core as patient fibrils with reduced stability.
    Pradhan T; Annamalai K; Sarkar R; Huhn S; Hegenbart U; Schönland S; Fändrich M; Reif B
    J Biol Chem; 2020 Dec; 295(52):18474-18484. PubMed ID: 33093170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody.
    Wall JS; Kennel SJ; Paulus M; Gregor J; Richey T; Avenell J; Yap J; Townsend D; Weiss DT; Solomon A
    J Nucl Med; 2006 Dec; 47(12):2016-24. PubMed ID: 17138745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis.
    Kola A; Baensch M; Bautsch W; Hennecke M; Klos A; Casaretto M; Köhl J
    Immunotechnology; 1996 Jun; 2(2):115-26. PubMed ID: 9373320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.
    Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL
    Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.